{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:59:08Z","timestamp":1790092748200,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejca.2024.113533","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T11:42:11Z","timestamp":1705923731000},"page":"113533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy"],"prefix":"10.1016","volume":"200","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica K.","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2024.113533_bib1","doi-asserted-by":"crossref","unstructured":"Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","DOI":"10.3322\/caac.21763"},{"key":"10.1016\/j.ejca.2024.113533_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2024.113533_bib5","first-page":"S3","article-title":"Why cancer staging? FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Benedet","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2024.113533_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ssu.10014","article-title":"TNM: evolution and relation to other prognostic factors","volume":"21","author":"Sobin","year":"2003","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib7","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2024.113533_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2024.113533_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2024.113533_bib10","doi-asserted-by":"crossref","first-page":"djv427","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2024.113533_bib11","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2024.113533_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113316","article-title":"Validation of the 2023 FIGO staging schema for advanced endometrial cancer","volume":"193","author":"Matsuo","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.113533_bib13","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.18632\/oncotarget.25550","article-title":"Trends and outcomes of women with synchronous endometrial and ovarian cancer","volume":"9","author":"Matsuo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2024.113533_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2017.09.027","article-title":"Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer","volume":"147","author":"Matsuo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00404-019-05288-5","article-title":"The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas","volume":"300","author":"Zhan","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejca.2024.113533_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","article-title":"Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases","volume":"94","author":"Soliman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejca.2024.113533_bib20","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the Corpus Uteri","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2024.113533_bib22","doi-asserted-by":"crossref","unstructured":"Scully R.E., Young R.H., Clement P.B., Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament, Atlas of Tumor Pathology, Armed Forces Institute of Pathology, Bethesda, MD, 1998.","DOI":"10.1097\/00004347-199907000-00019"},{"key":"10.1016\/j.ejca.2024.113533_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(85)80210-0","article-title":"Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases","volume":"16","author":"Ulbright","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2024.113533_bib24","doi-asserted-by":"crossref","first-page":"djv442","DOI":"10.1093\/jnci\/djv442","article-title":"Making a difference: distinguishing two primaries from metastasis in synchronous tumors of the ovary and uterus","volume":"108","author":"Dizon","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2024.113533_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2022.02.023","article-title":"Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification","volume":"165","author":"Matsuo","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajog.2020.10.045","article-title":"Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology","volume":"224","author":"Matsuo","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2024.113533_bib27","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1245\/s10434-021-09900-4","article-title":"Association between adjuvant therapy and survival in stage II-III endometrial cancer: influence of malignant peritoneal cytology","volume":"28","author":"Matsuo","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113317","article-title":"Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - an international pooled analysis of three ESGO accredited centres","volume":"193","author":"Schwameis","year":"2023","journal-title":"Eur J Cancer"},{"issue":"7447","key":"10.1016\/j.ejca.2024.113533_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2024.113533_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2017.03.017","article-title":"Surgical-pathological findings in type 1 and 2 endometrial cancer: an NRG Oncology\/Gynecologic Oncology Group study on GOG-210 protocol","volume":"145","author":"Creasman","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/his.13985","article-title":"Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances","volume":"76","author":"Casey","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2024.113533_bib32","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.113533_bib33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jso.24049","article-title":"Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer","volume":"112","author":"Matsuo","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2024.113533_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2021.10.085","article-title":"Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United States","volume":"164","author":"Matsuo","year":"2022","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:42:43Z","timestamp":1760733763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":29,"alternative-id":["S0959804924000091"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.113533","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.113533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113533"}}